We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Grindr
GRND
$3.19B
| $3.44M | 0.02% |
151,330
| – | – |
|
627
NRG Energy
NRG
$24.7B
| $3.4M | 0.02% |
21,149
+4,035
| +24% | +$532K |
|
628
Extra Space Storage
EXR
$31.7B
| $3.38M | 0.02% |
22,954
-366,762
| -94% | -$53.4M |
|
629
M&T Bank
MTB
$36.7B
| $3.37M | 0.02% |
17,363
+3,345
| +24% | +$590K |
|
630
iShares Russell 1000 Growth ETF
IWF
$127B
| $3.36M | 0.02% |
+31,676
| New | +$3.03M |
|
631
Cheesecake Factory
CAKE
$5.26B
| $3.34M | 0.02% |
53,312
-39,352
| -42% | -$2.09M |
|
632
PG&E
PCG
$38.4B
| $3.31M | 0.02% |
237,720
+52,396
| +28% | +$852K |
|
633
A.O. Smith
AOS
$8.61B
| $3.28M | 0.02% |
50,040
-80,235
| -62% | -$5.25M |
|
634
State Street
STT
$50.9B
| $3.28M | 0.02% |
30,848
+6,476
| +27% | +$599K |
|
635
Iron Mountain
IRM
$37.3B
| $3.27M | 0.02% |
31,839
+7,097
| +29% | +$669K |
|
|
CPRX
636
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.27M | 0.02% |
150,478
-56,000
| -27% | -$1.32M |
|
637
Cloudflare
NET
$107B
| $3.26M | 0.02% |
+16,654
| New | +$2.42M |
|
|
DFTX
638
Definium Therapeutics
DFTX
$5.62B
| $3.26M | 0.02% |
502,198
-503,000
| -50% | -$3.31M |
|
639
Aflac
AFL
$63.7B
| $3.25M | 0.02% |
+30,837
| New | +$3.24M |
|
|
BCAX
640
Bicara Therapeutics
BCAX
$1.71B
| $3.24M | 0.02% |
348,690
| – | – |
|
641
Nucor
NUE
$62.4B
| $3.23M | 0.02% |
24,960
+23,094
| +1,238% | +$2.7M |
|
642
ArriVent BioPharma
AVBP
$1.47B
| $3.2M | 0.02% |
146,916
+543
| +0.4% | +$11.3K |
|
643
Carnival Corporation Ltd
CCL
$40.5B
| $3.19M | 0.02% |
113,571
+25,049
| +28% | +$536K |
|
644
Humana
HUM
$43.5B
| $3.19M | 0.02% |
13,055
+2,863
| +28% | +$714K |
|
645
SkinHealth Systems
SKIN
$91.4M
| $3.18M | 0.02% |
+1,666,030
| New | +$2.35M |
|
|
IPX
646
IperionX
IPX
$856M
| $3.15M | 0.02% |
+100,148
| New | +$2.26M |
|
647
Biomea Fusion
BMEA
$88.9M
| $3.14M | 0.02% |
1,743,834
+1,502,990
| +624% | +$2.9M |
|
648
Eaton
ETN
$173B
| $3.13M | 0.02% |
8,779
-136,524
| -94% | -$42M |
|
649
CSX Corp
CSX
$94.5B
| $3.12M | 0.02% |
95,640
-1,055,521
| -92% | -$31.8M |
|
650
Broadridge
BR
$19.5B
| $3.09M | 0.02% |
12,706
+2,820
| +29% | +$670K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.